Inventor
NAM SANGKIL
US19 patents
⚠️ This page may combine multiple inventors who share the name “NAM SANGKIL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOPE CITY
17 patentsUS9828342B2Nov 28, 2017
Isatin derivatives, pharmaceutical compositions thereof, and methods of use thereof
HOPE CITY19 citations81
US10703718B2Jul 7, 2020
5-bromo-indirubins
HOPE CITY2 citations73
US9856273B2Jan 2, 2018
ETP derivatives
HOPE CITY2 citations71
US9527868B2Dec 27, 2016
ETP derivatives
HOPE CITY3 citations71
US10435367B2Oct 8, 2019
Indirubin derivatives, and uses thereof
HOPE CITY3 citations70
US11306072B2Apr 19, 2022
5-bromo-indirubins
HOPE CITY2 citations68
US11964941B2Apr 23, 2024
5-Bromo-indirubins
HOPE CITY0 citations62
US11766442B2Sep 26, 2023
T-cell lymphoma treatments
HOPE CITY0 citations62
US11524937B2Dec 13, 2022
Indirubin derivatives, and uses thereof
HOPE CITY0 citations60
US10246471B2Apr 2, 2019
ETP derivatives
HOPE CITY1 citations60
US9512076B2Dec 6, 2016
Indirubin derivatives and uses thereof in treating chronic myelogenous leukemia
HOPE CITY2 citations60
US11584760B2Feb 21, 2023
Dithio ETP derivatives
HOPE CITY0 citations57
US10822353B2Nov 3, 2020
Dithio ETP derivatives
HOPE CITY1 citations57
US9233976B2Jan 12, 2016
Berbamine derivatives
HOPE CITY0 citations50
US7615638B2Nov 10, 2009
Synthesis of grossularines-1 and analogs thereof and method of use
HOPE CITY1 citations48
US11117894B2Sep 14, 2021
Pyridopyrazine compounds and uses thereof
HOPE CITY0 citations45
US11213510B2Jan 4, 2022
Thioindirubins
HOPE CITY0 citations43